XTRA:SRT3Life Sciences
Sartorius (XTRA:SRT3) Margin Recovery Reinforces Bullish Narratives Despite High P/E
Sartorius (XTRA:SRT3) opened 2026 with Q1 results framed by trailing 12 month revenue of €3.5b and basic EPS of €2.24, alongside net income of €154.9m that reflects the latest phase of its earnings recovery story. Over the past year, revenue has moved from €3.4b to €3.5b, while basic EPS on a trailing 12 month basis has gone from €1.22 to €2.24 as net income increased from €84m to €154.9m. Together, these figures give a clearer picture of how the topline and bottom line have been tracking...